Skip to content

Aurinia Pharmaceuticals

US · AUPH #2749 by market cap Listed 1970
14.70 -0.19 -1.28%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Aurinia Pharmaceuticals

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Founded
1993
CEO
Mr. Kevin C. Tang
Employees
128
Headquarters
Edmonton, Alberta, Canada
Fiscal year end
12-31
Website
auriniapharma.com

Company profile

Exchange
US
Symbol
AUPH
Market-cap rank
#2749
Listing date
1970-01-01
Market cap
1.97B
Float cap
1.91B
Shares out
134.00M
Float shares
130.11M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:02:19 · For reference only, not investment advice and not tailored to your situation.

Aurinia Pharmaceuticals discussion 0 comments

Add a comment